International Journal of Women's Dermatology (Oct 2024)
Patient needs in women of childbearing age with psoriasis: retrospective analysis from the German PsoBest registry
Abstract
Background:. Women of childbearing age (WoCBA) with psoriasis face additional burden related to contraindications of systemic treatments during pregnancy/lactation and to the physical and psychosocial impact of psoriasis on their intimate/sexual relationships. Objective:. Within a people-centered health care model, this study aimed to identify specific patient needs and their correlates in WoCBA (18–45 years), in comparison to same-age men and women above 45 years. Methods:. Baseline data from the German PsoBest registry, including patients with moderate/severe plaque-type psoriasis with the indication for systemic therapy, were retrospectively analyzed. Psoriasis severity was assessed with the Psoriasis Area and Severity Index and patient-reported outcomes included EuroQoL Visual Analogue Scale, Dermatology Life Quality Index (DLQI), and Patient Needs Questionnaire. Results:. The participants were 2308 WoCBA, 3634 men between 18 and 45 years of age, and 3401 women older than 45 years. In comparison to both control groups, WoCBA reported more DLQI impairments and higher needs to reduce social impairments (eg, “to be able to lead a normal working life”; “to be less burdened in your partnership”; “to be able to have a normal sex life”). These patient needs were associated with having psoriasis arthritis, previous systemic therapy, worse general health, and more DLQI impairments. Limitations:. Retrospective analysis of an established dataset limited the examination of specific developmental, sexual, and reproductive variables. Conclusion:. The specific needs of WoCBA with psoriasis were particularly related to the work context/financial stability and intimate relationships, which are crucial aspects in family planning. These results claim for a sex/age-sensitive approach in the psoriasis health care, by considering these needs as qualifiers in the clinical decision for systemic treatment.